Compare Resonac Holdings Corp. with Similar Stocks
Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Operating profit has grown by an annual rate 37.91% of over the last 5 years
- The company is Net-Debt Free
2
Poor long term growth as Operating profit has grown by an annual rate 37.91% of over the last 5 years
3
The company declared negative results in Mar'25 after positive results in Dec'24
4
With ROCE of 4.19%, it has a very expensive valuation with a 2.03 Enterprise value to Capital Employed
Stock DNA
Specialty Chemicals
JPY 2,882,611 Million (Large Cap)
68.00
NA
0.01%
0.99
4.44%
4.12
Revenue and Profits:
Net Sales:
360,862 Million
(Quarterly Results - Dec 2025)
Net Profit:
23,955 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
82.05%
0%
82.05%
6 Months
179.62%
0%
179.62%
1 Year
504.12%
0%
504.12%
2 Years
359.24%
0%
359.24%
3 Years
646.27%
0%
646.27%
4 Years
521.6%
0%
521.6%
5 Years
356.49%
0%
356.49%
Resonac Holdings Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.71%
EBIT Growth (5y)
37.91%
EBIT to Interest (avg)
3.47
Debt to EBITDA (avg)
5.56
Net Debt to Equity (avg)
1.12
Sales to Capital Employed (avg)
0.83
Tax Ratio
25.00%
Dividend Payout Ratio
40.50%
Pledged Shares
0
Institutional Holding
0.04%
ROCE (avg)
3.42%
ROE (avg)
7.34%
Valuation key factors
Factor
Value
P/E Ratio
68
Industry P/E
Price to Book Value
3.04
EV to EBIT
48.45
EV to EBITDA
18.48
EV to Capital Employed
2.03
EV to Sales
2.09
PEG Ratio
NA
Dividend Yield
0.01%
ROCE (Latest)
4.19%
ROE (Latest)
4.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Dec 2016
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.04%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
360,862.00
344,209.00
4.84%
Operating Profit (PBDIT) excl Other Income
47,927.00
22,506.00
112.95%
Interest
4,793.00
1,926.00
148.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
23,955.00
-12,827.00
286.75%
Operating Profit Margin (Excl OI)
68.50%
-3.10%
7.16%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 4.84% vs 7.25% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 286.75% vs -212.06% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,347,125.00
1,391,480.00
-3.19%
Operating Profit (PBDIT) excl Other Income
203,399.00
166,189.00
22.39%
Interest
13,511.00
15,942.00
-15.25%
Exceptional Items
-53,835.00
-4,072.00
-1,222.08%
Consolidate Net Profit
31,048.00
74,772.00
-58.48%
Operating Profit Margin (Excl OI)
81.00%
49.00%
3.20%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -3.19% vs 7.42% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -58.48% vs 1,247.34% in Dec 2024
About Resonac Holdings Corp. 
Resonac Holdings Corp.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






